Inventor
WIEBE ANITA
DE74 patents
Patents
50 patentsUS10238725B2Mar 26, 2019
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH7 citations93
US10064926B2Sep 4, 2018
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH12 citations90
US11123370B2Sep 21, 2021
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US11058726B2Jul 13, 2021
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US10842817B2Nov 24, 2020
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US10780125B2Sep 22, 2020
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US10525084B2Jan 7, 2020
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH3 citations84
US10526386B2Jan 7, 2020
Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH7 citations84
US10513547B2Dec 24, 2019
Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations84
US10457712B2Oct 29, 2019
Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations84
US10442844B2Oct 15, 2019
Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations84
US10435448B2Oct 8, 2019
Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations84
US10398766B2Sep 3, 2019
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH5 citations84
US10363295B2Jul 30, 2019
Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US10335474B2Jul 2, 2019
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US10335475B2Jul 2, 2019
Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH5 citations84
US10314898B2Jun 11, 2019
Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US10293036B2May 21, 2019
Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US10238726B2Mar 26, 2019
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US10238724B2Mar 26, 2019
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations84
US10221225B2Mar 5, 2019
Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations84
US10195232B1Feb 5, 2019
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US10117916B2Nov 6, 2018
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US10064928B2Sep 4, 2018
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations84
US12275776B2Apr 15, 2025
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US12275775B2Apr 15, 2025
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US12221468B2Feb 11, 2025
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US11786583B2Oct 17, 2023
Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US11679147B2Jun 20, 2023
Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US11672848B2Jun 13, 2023
Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US11576956B2Feb 14, 2023
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US11260115B1Mar 1, 2022
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US11083784B2Aug 10, 2021
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10722566B2Jul 28, 2020
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10722536B1Jul 28, 2020
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10688131B2Jun 23, 2020
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10668100B1Jun 2, 2020
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10653762B2May 19, 2020
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10653761B2May 19, 2020
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10596196B2Mar 24, 2020
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10357550B2Jul 23, 2019
Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations73
US10272114B1Apr 30, 2019
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10238691B1Mar 26, 2019
Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US12180256B2Dec 31, 2024
Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
US12150979B2Nov 26, 2024
Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
US12036271B2Jul 16, 2024
Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
US11897935B2Feb 13, 2024
Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
US11897936B2Feb 13, 2024
Peptides, combination of peptides as targets and for use in immunotherapy
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
US11597752B2Mar 7, 2023
Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
US11117951B2Sep 14, 2021
Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
Showing the top 50 of 74 patents by PatentIndex Score.